» Articles » PMID: 39524739

Functional Characterization and Unraveling the Structural Determinants of Novel Steroid Hydroxylase CYP154C7 from Sp. PAMC26508

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Nov 11
PMID 39524739
Authors
Affiliations
Soon will be listed here.
Abstract

This study characterized cytochrome P450 enzyme CYP154C7 from sp. PAMC26508, emphasizing its capability to hydroxylate steroids, especially at the 16α-position. The enzymatic assay of CYP154C7 demonstrated effective conversion across a pH range of 7.2-7.6, with optimal activity at 30 °C in the Pdx/PdR plus NADH system. Kinetic analysis on most converted steroids (androstenedione and adrenosterone) was performed which shows a greater affinity for androstenedione ( , 11.06 ± 1.903 μM; , 0.0062 ± 0.0002 sec) compared to adrenosterone ( , 34.50 ± 6.2 μM; , 0.0119 ± 0.0007 sec). A whole-cell system in , overexpressing recombinant CYP154C7, achieved substantial conversion for steroids, indicating that CYP154C7 can also be used as a potential whole-cell biocatalyst. To gain structural insights, homology models of CYP154C7 and its homologs were constructed using CYP154C5 (PDB ID: 6TO2), refined, validated, and used for docking studies. Comparative docking analysis suggests that lysine (K236) in the active site and tyrosine (Y197) in the substrate access channel of CYP154C7 are crucial for substrate selectivity and catalytic efficiency. This study suggests that CYP154C7 could be a promising candidate for developing modified steroids, providing valuable insights for protein engineering to design commercially useful CYP steroid hydroxylases with diverse substrate specificities.

References
1.
Nikolaus J, Nguyen K, Virus C, Riehm J, Hutter M, Bernhardt R . Engineering of CYP106A2 for steroid 9α- and 6β-hydroxylation. Steroids. 2017; 120:41-48. DOI: 10.1016/j.steroids.2017.01.005. View

2.
Bakkes P, Riehm J, Sagadin T, Ruhlmann A, Schubert P, Biemann S . Engineering of versatile redox partner fusions that support monooxygenase activity of functionally diverse cytochrome P450s. Sci Rep. 2017; 7(1):9570. PMC: 5575160. DOI: 10.1038/s41598-017-10075-w. View

3.
Schmitz D, Janocha S, Kiss F, Bernhardt R . CYP106A2-A versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds. Biochim Biophys Acta Proteins Proteom. 2017; 1866(1):11-22. DOI: 10.1016/j.bbapap.2017.07.011. View

4.
Eisenberg D, Luthy R, Bowie J . VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 1997; 277:396-404. DOI: 10.1016/s0076-6879(97)77022-8. View

5.
Nelson D . Cytochrome P450 diversity in the tree of life. Biochim Biophys Acta Proteins Proteom. 2017; 1866(1):141-154. PMC: 5681887. DOI: 10.1016/j.bbapap.2017.05.003. View